Cardiopulmonary bypass

Cardiopulmonary Bypass
Joe McBrine
Cardiopulmonary Bypass.ppt

Biofluid Dynamics of The Cardiopulmonary Bypass Surgery
John Ramirez, Karym Urdaneta, Jesse Castillo, Victor Delgado
Biofluid Dynamics of The Cardiopulmonary Bypass Surgery.ppt

Cardiac Anesthesia
Dennis Stevens CRNA, MSN, ARNP
Cardiac Anesthesia.ppt

Coronary Artery Bypass Graft
Joshua Paul Aronson
Coronary Artery Bypass Graft CABG.ppt

Minimally Invasive Surgical Techniques and Instruments
David Ramsay
Minimally Invasive Surgical Techniques and Instruments.ppt

Vigilance, Treatment and Reporting
TransfusionReactions.ppt

Off-Pump Coronary Artery Bypass Surgical & Anesthetic Concerns
Brian D-L Marasigan, M.D.

Off-Pump Coronary Artery Bypass.ppt

Magnesium Discussion Pro and Con
Eugene Yevstratov MD
Magnesium Discussion Pro and Con.ppt

Coronary Artery Bypass Graft
Dr. Aidah Alkaissi
Coronary Artery Bypass Graft.ppt

Postoperative Care in the Patient With Congenital Heart Disease
Postopcardiaccare.ppt

ECMO AND Sepsis
Sean Skinner, MD
ECMO AND Sepsis.ppt

Hemostasis as a perfusion problem
Hemostasis as a perfusion problem.ppt

Neuroprotection for surgery: Is it possible?
Philip Bickler, MD, PhD
ClinicalNeuroprotect.ppt

Shock
Stephanie N. Sudikoff, MD
Shock.ppt

Updates from the New American College of Chest Physicians
Updates from the New American College of Chest Physicians.ppt

Glycemic Control in the Hospitalized Patient
Glycemic Control in the Hospitalized Patient.ppt

Soluble Fibrin
Soluble Fibrin.ppt

Cardiac Transplantation Board Review
Brian W. Zagol, M.D.
Cardiac Transplantation Board Review.ppt

Management of Infants requiring ECMO
Sixto F. Guiang
ECMO.ppt 
200 free full text scholarly articles

1. Cross-clamping of the descending thoracic aorta leads to the asymmetrical distribution of propofol during cardiopulmonary bypass surgery.
2. [Effects of ulinastatin on coagulation in children after cardiopulmonary bypass].
3. The effect of conventional and mini-invasive cardiopulmonary bypass on neutrophil activation in patients undergoing coronary artery bypass grafting.
4. Infusion of low-dose vasopressin improves left ventricular function during separation from cardiopulmonary bypass: A double-blind randomized study.
5. STAT3 Regulates Monocyte TNF-Alpha Production in Systemic Inflammation Caused by Cardiac Surgery with Cardiopulmonary Bypass.
6. Novel strategy to improve end-organ function with pulsatile cardiopulmonary bypass.
7. Pulsatile cardiopulmonary bypass with intra-aortic balloon pump improves organ function and reduces endothelial activation.
8. Platelet function in stored heparinised autologous blood is not superior to in patient platelet function during routine cardiopulmonary bypass.
9. Impact of a large hemodialysis arteriovenous fistula: on myocardial protection during cardiopulmonary bypass.
10. Effect of cardiopulmonary bypass on tissue injury markers and endothelial activation during coronary artery bypass graft surgery.
11. Abrupt formation of intracardiac thrombus during cardiopulmonary bypass with full heparinization -A case report-.
12. Effects of ulinastatin treatment on myocardial and renal injury in patients undergoing aortic valve replacement with cardiopulmonary bypass.
13. Surgical treatment of lone atrial fibrillation by mid-sternotomy Maze procedure under standard cardiopulmonary bypass.
14. Retrograde autologous priming in cardiopulmonary bypass in adult patients: effects on blood transfusion and hemodilution.
15. SjO2/SvO2 correlation during pediatric cardiac surgery with cardiopulmonary bypass.
16. Challenges encountered with argatroban anticoagulation during cardiopulmonary bypass.
17. Cardiopulmonary bypass model in the rat: a new minimal invasive model with a low flow volume.
18. Successful treatment of severe accidental hypothermia with cardiac arrest for a long time using cardiopulmonary bypass - report of a case.
19. A case-controlled evaluation of the Medtronic Resting Heart System compared with conventional cardiopulmonary bypass in patients undergoing isolated coronary artery bypass surgery.
20. Acute post-cardiopulmonary bypass left atrial thrombosis after mitral valvuloplasty and left atrial thrombectomy.
21. Irreversible loss of vision in a paediatric patient due to occipital infarction after cardiopulmonary bypass.
22. The effect of cardiopulmonary bypass in coronary artery bypass surgeries (on-pump versus off-pump) on erectile function and endothelium-derived nitric oxide levels.
23. Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit?
24. A simple method for occlusion of both venae cavae in total cardiopulmonary bypass for robotic surgery.
25. A case report and brief review of the literature on bilateral retinal infarction following cardiopulmonary bypass for coronary artery bypass grafting.
26. Myocardial revascularization without cardiopulmonary bypass: historical background and thirty-year experience.
27. A case of left atrial metastasis from hepatocellular carcinoma: life-saving palliative resection using cardiopulmonary bypass.
28. Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial.
29. [Protection of noninvasive limb ischemic preconditioning on myocardium in patients undergoing heart valve surgery under cardiopulmonary bypass].
30. Temporary bilateral sensorineural hearing loss following cardiopulmonary bypass -A case report-.
31. A case of carinal schwannoma resected under cardiopulmonary bypass.
32. Vacuum-assisted venous drainage in cardiopulmonary bypass and need of blood transfusion: experience of service.
33. Predictors of mortality in patients over 70 years-old undergoing CABG or valve surgery with cardiopulmonary bypass.
34. Nitrite exhaled breath condensate study in patients undergoing cardiopulmonary bypass cardiac surgery.
35. [Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].
36. Entropy score, patent ductus arteriosus (PDA), and cardiopulmonary bypass (CPB): ligation of PDA on CPB can compromise cerebral blood flow.
37. Effect of short-acting beta blocker on the cardiac recovery after cardiopulmonary bypass.
38. Perioperative risk factors for prolonged mechanical ventilation and tracheostomy in women undergoing coronary artery bypass graft with cardiopulmonary bypass.
39. Changes in myocardial lactate, pyruvate and lactate-pyruvate ratio during cardiopulmonary bypass for elective adult cardiac surgery: Early indicator of morbidity.
40. A marked increase in gastric fluid volume during cardiopulmonary bypass.
41. Is it necessary to stent renal artery stenosis patients before cardiopulmonary bypass procedures?
42. [The incidence of thrombocytopenia after cardiopulmonary bypass in children with Down syndrome].
43. Unmasking of patent ductus arteriosus on cardiopulmonary bypass: role of intraoperative trans-esophageal echocardiography in a patient with severe pulmonary hypertension due to pulmonary vein stenosis and cor triatriatum.
44. Antiphospholipid syndrome, cardiac surgery and cardiopulmonary bypass.
45. [Kidney injury after cardiopulmonary bypass in infants with congenital heart disease].
46. Effects of penehyclidine hydrochloride on rat intestinal barrier function during cardiopulmonary bypass.
47. Computed tomography assessment of lung structure in patients undergoing cardiac surgery with cardiopulmonary bypass.
48. Patient with posterior mediastinal mass requiring urgent cardiopulmonary bypass.
49. Microcirculation after cardiopulmonary bypass: a glance at the mesenteric mucosa.
50. Total percutaneous cardiopulmonary bypass with Perclose ProGlide.
51. Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass.
52. Combined heart-liver transplantation with extended cardiopulmonary bypass.
53. Kidney-specific proteins in elderly patients undergoing cardiac surgery with cardiopulmonary bypass: Retraction.
54. Prospective, open-label investigation of the pharmacokinetics of daptomycin during cardiopulmonary bypass surgery.
55. [Experiences of cardiopulmonary bypass in the treatment of locally advanced pulmonary malignant tumors].
56. Postoperative cognitive deficit after cardiopulmonary bypass with preserved cerebral oxygenation: a prospective observational pilot study.
57. Cardiopulmonary bypass-associated acute kidney injury.
58. Epsilon-aminocaproic acid, neonates, and cardiopulmonary bypass.
59. Avoiding cardiopulmonary bypass does not protect against neuropsychiatric complications in elderly patients.
60. Endotoxemia related to cardiopulmonary bypass is associated with increased risk of infection after cardiac surgery: a prospective observational study.
61. Administration of hydrogen sulfide via extracorporeal membrane lung ventilation in sheep with partial cardiopulmonary bypass perfusion: a proof of concept study on metabolic and vasomotor effects.
62. Serum markers are not reliable measures of renal function in conjunction with cardiopulmonary bypass.
63. Should double lung transplant be performed with or without cardiopulmonary bypass?
64. Detrimental effect of cardiopulmonary bypass (CPB) on malignant disease.
65. Mini-cardiopulmonary bypass impact on blood conservation strategy in coronary artery bypass grafting.
66. Plasma acetate, gluconate and interleukin-6 profiles during and after cardiopulmonary bypass: a comparison of Plasma-Lyte 148 with a bicarbonate-balanced solution.
67. A new extracorporeal vacuum-assisted device to optimize cardiopulmonary bypass. Comparison with the conventional system.
68. Femoro-femoral cardiopulmonary bypass for the resection of an anterior mediastinal mass.
69. Ketamine has no effect on oxygenation indices following elective coronary artery bypass grafting under cardiopulmonary bypass.
70. Postconditioning of the lungs with inhaled carbon monoxide after cardiopulmonary bypass in pigs.
71. Does avoidance of cardiopulmonary bypass confer any benefits in octogenarians undergoing coronary surgery?
72. Continuous S-(+)-ketamine administration during elective coronary artery bypass graft surgery attenuates pro-inflammatory cytokine response during and after cardiopulmonary bypass.
73. Enhanced thrombin generation after cardiopulmonary bypass surgery.
74. Can leucocyte depletion reduce reperfusion injury following cardiopulmonary bypass?
75. Pediatric cardiopulmonary bypass adaptations for long-term survival of baboons undergoing pulmonary artery replacement.
76. Isoflurane pre-treatment before cardiopulmonary bypass alleviates neutrophil accumulation in dog lungs.
77. Salmonella sepsis simulating gastrointestinal ischaemia following cardiopulmonary bypass.
78. Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass.
79. Effects of inosine on reperfusion injury after cardiopulmonary bypass.
80. Advanced lung cancer invading the left atrium, treated with pneumonectomy combined with left atrium resection under cardiopulmonary bypass.
81. Leukocyte depletion during cardiopulmonary bypass in routine adult cardiac surgery.
82. Myocardial contractile function in survived neonatal piglets after cardiopulmonary bypass.
83. Pulmonary artery perfusion with HTK solution prevents lung injury in infants after cardiopulmonary bypass.
84. Successful repair of injured hepatic veins and inferior vena cava following blunt traumatic injury, by using cardiopulmonary bypass and hypothermic circulatory arrest.
85. Prevalence of and risk factors for perioperative arrhythmias in neonates and children after cardiopulmonary bypass: continuous holter monitoring before and for three days after surgery.
86. Additional lung-protective perfusion techniques during cardiopulmonary bypass.
87. Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis.
88. Effects of cardiopulmonary bypass on endothelin-1-induced contraction and signaling in human skeletal muscle microcirculation.
89. Combined coronary artery bypass grafting and aortic valve replacement with minimal extracorporeal closed circuit circulation versus standard cardiopulmonary bypass.
90. The relationship between inflammatory activation and clinical outcome after infant cardiopulmonary bypass.
91. Cardiopulmonary bypass line sternal wrapping: technical tips.
92. Difference between pre-operative and cardiopulmonary bypass mean arterial pressure is independently associated with early cardiac surgery-associated acute kidney injury.
93. Blood hibernation: a novel strategy to inhibit systemic inflammation and coagulation induced by cardiopulmonary bypass.
94. Antithrombin-heparin covalent complex reduces microemboli during cardiopulmonary bypass in a pig model.
95. Optimized temporary biventricular pacing acutely improves intraoperative cardiac output after weaning from cardiopulmonary bypass: a substudy of a randomized clinical trial.
96. Cerebral emboli detected by transcranial Doppler during cardiopulmonary bypass are not correlated with postoperative cognitive deficits.
97. Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine model.
98. Venous obstruction and cerebral perfusion during experimental cardiopulmonary bypass.
99. [Compartment syndrome after cardiopulmonary bypass].
100. Central venous oxygen saturation and blood lactate levels during cardiopulmonary bypass are associated with outcome after pediatric cardiac surgery.
101. Modified ultrafiltration attenuates pulmonary-derived inflammatory mediators in response to cardiopulmonary bypass.
102. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass.
103. Real-time continuous monitoring of cerebral blood flow autoregulation using near-infrared spectroscopy in patients undergoing cardiopulmonary bypass.
104. Relationship of internal jugular venous oxygen saturation and perfusion flow rate in children and adults during normothermic and hypothermic cardiopulmonary bypass.
105. Hemodynamic stability during biventricular pacing after cardiopulmonary bypass.
106. Effect of deep hypothermic circulatory arrest followed by low-flow cardiopulmonary bypass on brain metabolism in newborn piglets: comparison of pH-stat and α-stat management.
107. Coronary bypass surgery in a 105-year-old patient with cardiopulmonary bypass.
108. Bidirectional Glenn procedure without cardiopulmonary bypass in a patient with left juxtaposed atrial appendages.
109. Assessment of aprotinin in the reduction of inflammatory systemic response in children undergoing surgery with cardiopulmonary bypass.
110. Use of nefidipine and acute kidney injury incidence in postoperative of myocardial revascularization surgery with cardiopulmonary bypass.
111. Two scimitar veins in an adult: repair through a right thoracotomy without cardiopulmonary bypass.
112. Serum cystatin C is an early predictive biomarker of acute kidney injury after pediatric cardiopulmonary bypass.
113. Phenotypic commitment of monocytes towards a protective hemoglobin scavenging phenotype (CD14(pos)CD163(high)HLA-DR(low))following cardiopulmonary bypass.
114. Letter by Gomes and Evora regarding article, "Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome".
115. Effect of anaesthesia and cardiopulmonary bypass on blood endocannabinoid concentrations during cardiac surgery.
116. Plasma cystatin C and acute kidney injury after cardiopulmonary bypass.
117. Aprotinin improves functional outcome but not cerebral infarct size in an experimental model of stroke during cardiopulmonary bypass.
118. Inhaled carbon monoxide prevents acute kidney injury in pigs after cardiopulmonary bypass by inducing a heat shock response.
119. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
120. Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass.
121. Relationship between anesthetic depth and venous oxygen saturation during cardiopulmonary bypass.
122. Apoptosis during CABG surgery with the use of cardiopulmonary bypass is prominent in ventricular but not in atrial myocardium.
123. Hawley H. Seiler Resident Award. Transcriptional profile of brain injury in hypothermic circulatory arrest and cardiopulmonary bypass.
124. Thromboresistant cardiopulmonary bypass circuits: room for improvement?
125. Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury.
126. Atrial septal defect closure on cardiopulmonary bypass in a sickle cell anemia: role of hydroxyurea and partial exchange transfusion.
127. Electroencephalographic seizures after neonatal cardiac surgery with high-flow cardiopulmonary bypass.
128. Differential neuronal vulnerability varies according to specific cardiopulmonary bypass insult in a porcine survival model.
129. Silent meningioma - a rare cause of stroke in post-cardiopulmonary bypass patients.
130. [Clinical profile of systemic inflammatory response after pediatric cardiac surgery with cardiopulmonary bypass].
131. Relative adrenal insufficiency and hemodynamic status in cardiopulmonary bypass surgery patients. A prospective cohort study.
132. The risk of performing cardiopulmonary bypass in malaria patients: a small case series.
133. A lipopolysaccharide adsorber in adult cardiopulmonary bypass: a single centre randomised controlled pilot trial.
134. Effect of a neutrophil elastase inhibitor on acute lung injury after cardiopulmonary bypass.
135. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery.
136. Approach for surgical correction of pulmonary artery coarctation without cardiopulmonary bypass.
137. Flow visualization in blood aspirator and cardiotomy reservoir used in cardiopulmonary bypass.
138. Assisted venous drainage on cardiopulmonary bypass for minimally invasive aortic valve replacement: is it necessary, useful or desirable?
139. [Effect of ulinastatin on perioperative inflammatory response to coronary artery bypass grafting with cardiopulmonary bypass].
140. The relationship among thromboelastography, hemostatic variables, and bleeding after cardiopulmonary bypass surgery in children.
141. Activated partial thromboplastin time waveform analysis as specific sepsis marker in cardiopulmonary bypass surgery.
142. Cardiopulmonary bypass increases permeability of the blood-cerebrospinal fluid barrier.
143. Inflammatory brain injury after cardiopulmonary bypass: is it real?
144. Cardiopulmonary bypass--are pediatric patients safer now?
145. Strategies to prevent intraoperative lung injury during cardiopulmonary bypass.
146. Argatroban as a substitute of heparin during cardiopulmonary bypass: a safe alternative?
147. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
148. Effect of hydrogen sulfide on myocardial protection in the setting of cardioplegia and cardiopulmonary bypass.
149. Detection and elimination of microemboli related to cardiopulmonary bypass.
150. eComment: Cardiopulmonary bypass without exchange transfusion in sickle cell disease--an update.
151. Axillary artery in cardiopulmonary bypass: indications and results.
152. Does aprotinin preserve platelets in children with acyanogenic congenital heart disease undergone surgery with cardiopulmonary bypass?
153. Cystatin C and glomerular filtration rate in the cardiac surgery with cardiopulmonary bypass.
154. Impaired autoregulation of cerebral blood flow during rewarming from hypothermic cardiopulmonary bypass and its potential association with stroke.
155. [Protective effect of aminophylline on cerebral injury during cardiopulmonary bypass in infants].
156. Early induction of hypothermia during cardiac arrest improves neurological outcomes in patients with out-of-hospital cardiac arrest who undergo emergency cardiopulmonary bypass and percutaneous coronary intervention.
157. Hemofiltration during cardiopulmonary bypass does not decrease the incidence of atrial fibrillation after cardiac surgery.
158. [Surgical management of retroperitoneal metastatic testicular tumor with inferior vena caval thrombus using cardiopulmonary bypass, arrested circulation, and profound hypothermia: a case report].
159. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
160. Anesth Analg. 2009 Dec;109(6):1752-62. Retraction in: Shafer SL. Anesth Analg. 2010 Dec;111(6):1567.
161. A core review of temperature regimens and neuroprotection during cardiopulmonary bypass: does rewarming rate matter?
162. PRO: Temperature regimens and neuroprotection during cardiopulmonary bypass: does rewarming rate matter?
163. CON: Temperature regimens and neuroprotection during cardiopulmonary bypass: does rewarming rate matter?
164. [SB203580 reduces proinflammatory cytokine production in rats after cardiopulmonary bypass].
165. Impact of xenon anaesthesia in isolated cardiopulmonary bypass on very early leucocyte and platelet activation and clearance: a randomized, controlled study.
166. Effect of cardiopulmonary bypass on activated partial thromboplastin time waveform analysis, serum procalcitonin and C-reactive protein concentrations.
167. The impact of cardiopulmonary bypass on systemic interleukin-6 release, cerebral nuclear factor-kappa B expression, and neurocognitive outcome in rats.
168. Statin prophylaxis and inflammatory mediators following cardiopulmonary bypass: a systematic review.
169. Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome.
170. Analysis of the hydrodynamic profile in different roller pumps models used in cardiopulmonary bypass.
171. Pyruvate-fortified cardioplegia evokes myocardial erythropoietin signaling in swine undergoing cardiopulmonary bypass.
172. The effects of cardiopulmonary bypass on the number of cerebral microemboli and the incidence of cognitive dysfunction after coronary artery bypass graft surgery.
173. Surgical removal of a 'nonretrievable' inferior vena cava filter: a unique case requiring a median sternotomy and cardiopulmonary bypass.
174. The Response of Hemostatic Marker Levels to Activated Factor VII in a Neonate following Cardiopulmonary Bypass.
175. [Effects of ambroxol on renal function in children undergoing cardiopulmonary bypass].
176. Direct cannulation of the infrahepatic vena cava for emergent cardiopulmonary bypass support.
177. Interleukin-8 and acute kidney injury following cardiopulmonary bypass: a prospective cohort study.
178. Minimal extracorporeal circulation and off-pump compared to conventional cardiopulmonary bypass in coronary surgery.
179. [Intraoperative volume replacement: crystalloids versus colloids in surgical myocardial revascularization without cardiopulmonary bypass].
180. The effects of intra-operative amiodarone loading on the systemic inflammatory response syndrome induced by cardiopulmonary bypass.
181. Neutrophil gelatinase-associated lipocalin levels after use of mini-cardiopulmonary bypass system.
182. Altered coronary microvascular serotonin receptor expression after coronary artery bypass grafting with cardiopulmonary bypass.
183. Aprotinin protects the cerebral microcirculation during cardiopulmonary bypass.
184. Profound haemodilution during normothermic cardiopulmonary bypass influences neither gastrointestinal permeability nor cytokine release in coronary artery bypass graft surgery.
185. The association of hemodilution and transfusion of red blood cells with biochemical markers of splanchnic and renal injury during cardiopulmonary bypass.
186. Brain, cardiopulmonary bypass and temperature: what should we be doing?
187. The effects of normoxic versus hyperoxic cardiopulmonary bypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing open cardiac surgery: a randomized controlled trial.
188. Increased vascular permeability after cardiopulmonary bypass in patients with diabetes is associated with increased expression of vascular endothelial growth factor and hepatocyte growth factor.
189. Cardiopulmonary bypass induced microcirculatory injury of the small bowel in rats.
190. Aortic valve replacement with minimal extracorporeal circulation versus standard cardiopulmonary bypass.
191. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass.
192. Resection of a giant malignant mediastinal peripheral nerve sheath tumour under cardiopulmonary bypass.
193. The association of renal dysfunction and the use of aprotinin in patients undergoing congenital cardiac surgery requiring cardiopulmonary bypass.
194. Operation of coarctation with saccular aneurysm of descending aorta under support of low flow cardiopulmonary bypass.
195. Predictors of inotrope use in patients undergoing concomitant coronary artery bypass graft (CABG) and aortic valve replacement (AVR) surgeries at separation from cardiopulmonary bypass (CPB).
196. Evaluation of exhaled nitric oxide in patients undergoing myocardial revascularization with cardiopulmonary bypass.
197. Evolution of cardiopulmonary bypass.
198. Aprotinin concentration varies significantly according to cardiopulmonary bypass conditions.
199. Effect of cardiopulmonary bypass on the pharmacokinetics of propranolol and atenolol.
200. An assessment of cardiopulmonary bypass-induced changes in platelet function using whole blood and classical light transmission aggregometry: the results of a pilot study.
201. Failure to wean from cardiopulmonary bypass due to left atrial compression by periaortic hematoma.